Zota Health Care Limited
NSE:ZOTA.NS
641.7 (INR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,804.885 | 1,399.569 | 1,311.931 | 1,067.892 | 951.127 | 856.294 | 778.515 | 715.8 | 647.333 | 564.634 | 501.116 | 439.081 | 381.43 |
| Cost of Revenue
| 1,472.358 | 832.697 | 893.071 | 757.472 | 685.487 | 593.179 | 533.995 | 451.491 | 447.069 | 392.035 | 361.49 | 318.669 | 276.526 |
| Gross Profit
| 332.527 | 566.872 | 418.86 | 310.42 | 265.64 | 263.115 | 244.52 | 264.308 | 200.264 | 172.599 | 139.626 | 120.412 | 104.904 |
| Gross Profit Ratio
| 0.184 | 0.405 | 0.319 | 0.291 | 0.279 | 0.307 | 0.314 | 0.369 | 0.309 | 0.306 | 0.279 | 0.274 | 0.275 |
| Reseach & Development Expenses
| 0 | 0.6 | 0.005 | 0.201 | 1.655 | 0.918 | 1.059 | 0.498 | 0.366 | 0.325 | 0.26 | 0.162 | 0 |
| General & Administrative Expenses
| 0 | 201.538 | 81.204 | 68.667 | 53.974 | 45.989 | 31.713 | 26.237 | 16.715 | 15.135 | 13.944 | 9.625 | 11.766 |
| Selling & Marketing Expenses
| 0 | 139.344 | 78.428 | 133.157 | 50.913 | 37.909 | 33.796 | 46.01 | 33.157 | 26.516 | 24.661 | 20.039 | 15.99 |
| SG&A
| 457.835 | 340.882 | 159.632 | 201.824 | 104.887 | 83.897 | 65.509 | 72.247 | 49.872 | 41.651 | 38.605 | 29.664 | 27.756 |
| Other Expenses
| 11.561 | 19.561 | 0.077 | 0.276 | 0.493 | 1.37 | 0.088 | 0.078 | 66.44 | 61.24 | 47.414 | 45.259 | 0.016 |
| Operating Expenses
| 457.835 | 613.086 | 306.838 | 331.889 | 239.866 | 197.455 | 144.873 | 174.421 | 116.312 | 102.891 | 86.019 | 74.923 | 70.509 |
| Operating Income
| -125.308 | -38.27 | 112.045 | -21.289 | 25.322 | 64.744 | 114.709 | 90.185 | 84.207 | 69.492 | 53.637 | 45.382 | 34.247 |
| Operating Income Ratio
| -0.069 | -0.027 | 0.085 | -0.02 | 0.027 | 0.076 | 0.147 | 0.126 | 0.13 | 0.123 | 0.107 | 0.103 | 0.09 |
| Total Other Income Expenses Net
| -36.321 | -8.641 | 12.303 | 17.635 | 13.293 | 13.814 | -1.291 | -6.568 | -6.32 | -6.289 | -6.665 | -7.484 | -4.632 |
| Income Before Tax
| -161.629 | -46.91 | 124.348 | -3.654 | 38.616 | 78.557 | 113.418 | 83.617 | 77.887 | 63.203 | 46.972 | 37.898 | 29.615 |
| Income Before Tax Ratio
| -0.09 | -0.034 | 0.095 | -0.003 | 0.041 | 0.092 | 0.146 | 0.117 | 0.12 | 0.112 | 0.094 | 0.086 | 0.078 |
| Income Tax Expense
| -18.151 | 10.817 | 35.308 | -1.565 | 11.2 | 23.073 | 40.742 | 28.206 | 26.029 | 20.6 | 15.674 | 12.353 | 9.781 |
| Net Income
| -143.479 | -57.728 | 89.076 | -2.089 | 27.415 | 55.484 | 72.677 | 55.411 | 51.857 | 42.603 | 31.298 | 25.545 | 19.834 |
| Net Income Ratio
| -0.079 | -0.041 | 0.068 | -0.002 | 0.029 | 0.065 | 0.093 | 0.077 | 0.08 | 0.075 | 0.062 | 0.058 | 0.052 |
| EPS
| -5.55 | -2.29 | 3.58 | -0.085 | 1.12 | 2.26 | 3.02 | 2.76 | 2.54 | 2.12 | 1.56 | 1.27 | 0.99 |
| EPS Diluted
| -5.55 | -2.29 | 3.58 | -0.085 | 1.12 | 2.26 | 3.02 | 2.76 | 2.54 | 2.12 | 1.56 | 1.27 | 0.99 |
| EBITDA
| 75.543 | 92.917 | 161.202 | 18.249 | 59.727 | 95.05 | 124.075 | 100.726 | 96.554 | 84.552 | 65.706 | 58.896 | 48.119 |
| EBITDA Ratio
| 0.042 | 0.066 | 0.123 | 0.017 | 0.063 | 0.111 | 0.159 | 0.141 | 0.149 | 0.15 | 0.131 | 0.134 | 0.126 |